Shutterstock
By André O. Hudson, Fidelma Fitzpatrick, Juliana Côrrea, Lori L. Burrows, Raúl Rivas González, Roy Robins-Browne, Yori Yuliandra
Monday, October 16, 2023 9:10 AM UTC
Almost since antibiotics were first discovered, we’ve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance.
The World Health Organization says we’re currently losing to the bugs, with resistance increasing and too few new antibiotics in the pipeline.
We wanted to know whether experts around the world think we will still have effective antibiotics in 50 years. Seven out of seven experts said yes.
Sign up for daily updates for the most important
stories unfolding in the global economy.
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
